|
"hsu cc"的相關文件
顯示項目 201-225 / 686 (共28頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2021-07-01 |
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Huang, YH;Hou, MC;Hwu, CM;Lo, YR;Shin, SJ;Hsu, CC |
| 國家衛生研究院 |
2021-07 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS;Wei, CC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-06-28 |
Behavioral and psychological symptoms in institutional residents with dementia in Taiwan
|
Hsieh, SW;Huang, LC;Hsieh, TJ;Lin, CF;Hsu, CC;Yang, YH |
| 國家衛生研究院 |
2021-06-22 |
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]
|
Huang, SS;Liao, WY;Hsu, CC;Chan, TS;Liao, TY;Yang, PM;Chen, LT;Sung, SY;Tsai, KK |
| 國家衛生研究院 |
2021-06-21 |
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
|
Liang, SK;Hsu, CC;Song, HL;Huang, YC;Kuo, CW;Yao, X;Li, CC;Yang, HC;Hung, YL;Chao, SY;Wu, SC;Tsai, FR;Chen, JK;Liao, WN;Cheng, SC;Tsou, TC;Wang, IC |
| 國家衛生研究院 |
2021-06-12 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS;Lai, JN;Wei, JCC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2021-05-31 |
A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells
|
Huang, SS;Liao, WY;Hsu, CC;Chan, TS;Liao, TY;Yang, PM;Chen, LT;Sung, SY;Tsai, KK |
| 國家衛生研究院 |
2021-04-29 |
Effect of dialyzer membranes on mortality in uremic patients undergoing long-term hemodialysis: A nationwide population-based study using the Taiwan dialysis registry data system 2005-2012
|
Chang, CY;Wu, MS;Chang, CH;Lin, CC;Lin, HL;Kao, CC;Chen, HH;Li, A;Hsu, CC;Lin, YC |
| 國家衛生研究院 |
2021-04-29 |
Urate-lowering therapy and chronic kidney disease development in patients with gout
|
Yen, FS;Wei, JCC;Chang, CL;Yang, CC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-03-26 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 Jan 29;Article in Press.]
|
Hsu, CC;Liao, WY;Chang, KY;Chan, TS;Huang, PJ;Chiang, CT;Shan, YS;Cheng, LH;Liao, TY;Tsai, KK |
| 國家衛生研究院 |
2021-03-05 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
|
Yen, FS;Hsu, CC;Su, YC;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2021-02-18 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS;Wei, JC;Lin, MC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-01-29 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer
|
Hsu, CC;Liao, WY;Chang, KY;Chan, TS;Huang, PJ;Chiang, CT;Shan, YS;Cheng, LH;Liao, TY;Tsai, KK |
| 國家衛生研究院 |
2021-01-14 |
Predictors of caregiver burden in aged caregivers of demented older patients
|
Tsai, CF;Hwang, WS;Lee, JJ;Wang, WF;Huang, LC;Huang, LK;Lee, WJ;Sung, PS;Liu, YC;Hsu, CC;Fuh, JL |
| 國家衛生研究院 |
2021-01-13 |
Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
|
Liao, CT;Zheng, CM;Lin, YC;Wu, MY;Lin, YF;Hsu, YH;Hsu, CC;Wu, MS |
| 國家衛生研究院 |
2021-01-10 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan
|
Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC |
| 國家衛生研究院 |
2021-01 |
The performance and crisis of Taiwan Smokers' Helpline in 2019
|
Hsu, CC;Chen, JH;Chen, SW |
| 中山醫學大學 |
2021 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS; Wei, JCC; Lin, MC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
TGR5 Expression Is Associated with Changes in the Heart and Urinary Bladder of Rats with Metabolic Syndrome
|
Hsu, CC; Cheng, KC; Li, YX; Hsu, PH; Cheng, JT; Niu, HS |
| 中山醫學大學 |
2021 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy A nationwide retrospective cohort study
|
Yen, FS; Hsu, CC; Su, YC; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2021 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
|
Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2021 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hsu, CC; Hou, MC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
|
Yen, FS; Wei, JCC; Chang, CL; Yang, CC; Hsu, CC; Hwu, CM |
顯示項目 201-225 / 686 (共28頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
|
